Literature DB >> 18537457

Pathophysiologic mechanisms of fibromyalgia and its related disorders.

Laurence A Bradley1.   

Abstract

This article reviews current findings regarding the pathophysiologic abnormalities that contribute to the enhanced pain responses of individuals with fibromyalgia as well as the relationships between fibromyalgia and commonly co-occurring disorders. Risk factors for fibromyalgia or enhanced pain responses include genetic and family influences, environmental triggers, and abnormal neuroendocrine and autonomic nervous system function. These risk factors also are associated with several disorders that frequently co-occur with fibromyalgia, such as major depressive disorder, migraine, and irritable bowel syndrome. Indeed, fibromyalgia and these co-occurring conditions may be part of a group of affective spectrum disorders that share important common, and perhaps heritable, causal factors. Recent research strongly suggests that alterations in central processing of sensory input also contribute to the cardinal symptoms of fibromyalgia, persistent widespread pain and enhanced pain sensitivity. Exposure to psychosocial and environmental stressors, as well as altered autonomic nervous system and neuroendocrine responses, also may contribute to alterations in pain perception or pain inhibition. Understanding the pathophysiology of fibromyalgia and co-occurring disorders may help clinicians provide the most appropriate treatment to their patients.

Entities:  

Mesh:

Year:  2008        PMID: 18537457

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  29 in total

Review 1.  Vitamin D and the occurrence of depression: causal association or circumstantial evidence?

Authors:  Elizabeth R Bertone-Johnson
Journal:  Nutr Rev       Date:  2009-08       Impact factor: 7.110

2.  Neonatal handling (resilience) attenuates water-avoidance stress induced enhancement of chronic mechanical hyperalgesia in the rat.

Authors:  Pedro Alvarez; Jon D Levine; Paul G Green
Journal:  Neurosci Lett       Date:  2015-01-28       Impact factor: 3.046

3.  Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis.

Authors:  Mark G Haviland; Kelly R Morton; Keiji Oda; Gary E Fraser
Journal:  Psychiatry Res       Date:  2010-04-10       Impact factor: 3.222

Review 4.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

5.  Non-invasive brain stimulation approaches to fibromyalgia pain.

Authors:  Baron Short; Jeffrey J Borckardt; Mark George; Will Beam; Scott T Reeves
Journal:  J Pain Manag       Date:  2009-01-01

6.  A tale of two comorbidities: Understanding the neurobiology of depression and pain.

Authors:  Meera Narasimhan; Nioaka Campbell
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

7.  Neurologic signs and symptoms in fibromyalgia.

Authors:  Nathaniel F Watson; Dedra Buchwald; Jack Goldberg; Carolyn Noonan; Richard G Ellenbogen
Journal:  Arthritis Rheum       Date:  2009-09

8.  Nociceptive and anxiety-like behavior in reproductively competent and reproductively senescent middle-aged rats.

Authors:  Alicia A Walf; Jason J Paris; Cheryl A Frye
Journal:  Gend Med       Date:  2009

Review 9.  Duloxetine: in patients with fibromyalgia.

Authors:  Monique P Curran
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

Review 10.  Challenges of functional imaging research of pain in children.

Authors:  Simona Sava; Alyssa A Lebel; David S Leslie; Athena Drosos; Charles Berde; Lino Becerra; David Borsook
Journal:  Mol Pain       Date:  2009-06-16       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.